Quetta Acquisition Files Form 12b-25 for Late 10-Q; Financial Statement Delay
Rhea-AI Filing Summary
Quetta Acquisition Corporation notified the SEC that it could not file its quarterly report for the period ended June 30, 2025 by the smaller-reporting-company deadline of August 14, 2025 because of a delay completing the required financial statement in the filing. The registrant states it was unable to eliminate the delay without unreasonable effort or expense and expects to submit the delayed Form 10-Q no later than the fifteenth calendar day after the prescribed due date. The filing also confirms that other periodic reports required over the prior 12 months have been filed and that no significant change in operating results is anticipated. The notice is signed by Hui Chen, Chief Executive Officer, who is listed as the contact with phone number (212) 612-1400.
Positive
- Formal notification filed: The company submitted a Form 12b-25 to disclose the late filing and reason.
- Plans to cure within 15 days: Management anticipates filing the delayed Quarterly Report within the permitted 15-calendar-day extension.
- Other reports current: The notice affirms that all other periodic reports required in the prior 12 months have been filed.
Negative
- Quarterly report late: The Form 10-Q for the quarter ended June 30, 2025, was not filed by the August 14, 2025 deadline applicable to smaller reporting companies.
- Delay in completing financial statement: The company attributes the late filing to a delay in completing the financial statement included in the Quarterly Report.
Insights
TL;DR: Routine late-filing notice due to financial statement delay; registrant expects to file within allowable 15-day cure period.
The registrant submitted a Form 12b-25 for an NT 10-Q, citing inability to complete the Quarterly Report for the period ended June 30, 2025, by the smaller-reporting-company deadline of August 14, 2025. Management attributes the delay specifically to completing the financial statement in the Quarterly Report and has elected relief under Rule 12b-25(b), indicating an intent to file within the 15-calendar-day extension. This is a procedural compliance matter rather than an explicit disclosure of adverse operating results; the filing also affirms that other periodic reports are current and that no significant change in results is anticipated.
TL;DR: Governance controls produced a timely notification; continuing disclosure appears intact pending the short delay.
The notification is signed by the CEO and provides a named contact, which reflects adherence to disclosure and accountability practices. By filing Form 12b-25, the company formally documents the reason for the missed deadline (completion of the financial statement) and invokes the prescribed cure period. The statement that all other required periodic reports for the prior 12 months have been filed and that no significant change in results is expected reduces immediate material governance concerns, though stakeholders will rely on the forthcoming Quarterly Report for full financial transparency.